Suppliers / Shanghai New Hualian Pharmaceutical

Shanghai New Hualian Pharmaceutical

China Updated 9 July 2026

Shanghai New Hualian Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file and one valid CEP across a filed portfolio of 2 molecules.

1
active US DMFs
1
valid CEPs
1
registered plants
1
filings across 1 regulators

Registered plants

Site FDA FEI
Shanghai, China Not on file

What they file, and where

Molecule Regulators Docs
Isotretinoin EDQM, SFDA (Saudi Arabia) 2
Hydrocortisone US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
EEC_EAEU 1 None

Comparing suppliers?

Choose your molecules and target markets. Shanghai New Hualian Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability